Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL28768643 | 1.00 | NAPRT (0.45) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL21225256 | 1.00 | NAPRT (0.45) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL27984081 | 0.98 | NAPRT (0.43) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL31249557 | 0.98 | NAPRT (0.43) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28970500 | 0.98 | NAPRT (0.43) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28907103 | 0.98 | NAPRT (0.43) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL27353707 | 0.91 | L3MBTL1 (0.43) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Pyridine SCHEMBL29166567 | 0.89 | NAPRT (0.39) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28324888 | 0.88 | TSHR (0.35) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3991498 | 0.87 | ALDH1A1 (0.38) | NAPRTTSHRTDP1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 927 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260121082-A1 | METAL-AIR CELL WITH PERFORMANCE ENHANCING ADDITIVE | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIV (US) | 2026-04-30 | — | — | US | claimed |
| CN-121574046-A | Synthesis method of 2, 2-triphenylacetophenone | 陕西缔都医药化工有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4700035-A1 | GLYCOSYLATION METHOD WITH PARTICIPATION OF TRIVALENT IODINE REAGENT | Huazhong University of Science and Technology (CN) | 2026-02-25 | — | — | EP | claimed |
| US-12431510-B2 | Metal-air cell with performance enhancing additive | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-09-30 | — | — | US | claimed |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | ADAMA MAKHTESHIM LTD. (IL) | 2025-05-29 | — | — | US | claimed |
| CN-120022375-A | Antibody drug conjugates based on metal N-heterocyclic carbene complexes, methods of preparation and use in anti-cancer therapy | 合成化学暨分子生物学有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250161506-A1 | Antibody Drug Conjugate Based on Metal N-Heterocyclic Carbene Complex, a Method of Preparing the Same and the Use of the Same in Anticancer Treatment | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-05-22 | — | — | US | claimed |
| US-12275753-B2 | Glycosylation method involving trivalent iodine reagent | HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-04-15 | — | — | US | claimed |
| CN-119758666-A | Antireflective composition, antireflective film and use thereof | 福建泓光半导体材料有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-20250092075-A1 | GLYCOSYLATION METHOD INVOLVING TRIVALENT IODINE REAGENT | HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-03-20 | — | — | US | claimed |
| US-20090035646-A1 | Swelling inhibition in batteries | SION POWER CORPORATION (US) | 2009-02-05 | — | — | US | claimed |
| WO-2009017726-A1 | SWELLING INHIBITION IN LITHIUM BATTERIES | SION POWER CORPORATION (US) | 2009-02-05 | — | — | WO | claimed |
| EP-1995252-A1 | METHOD FOR REMOVAL OF NUCLEIC ACID-PROTECTING GROUP | Nippon Shinyaku Co., Ltd. (JP) | 2008-11-26 | — | — | EP | claimed |
| EP-1986607-A2 | METHOD AND PROCESS FOR PREPARING CARDIOLIPIN | Neopharm, Inc. (US) | 2008-11-05 | — | — | EP | claimed |
| US-20070282097-A1 | Phosphoramidite Compound And Method For Producing Oligo-Rna | NIPPON SHINYAKU CO., LTD. (JP) | 2007-12-06 | — | — | US | claimed |
| WO-2007100808-A2 | METHOD AND PROCESS FOR PREPARING CARDIOLIPIN | NEOPHARM, INC. (US) | 2007-09-07 | — | — | WO | claimed |
| EP-1795536-A1 | PHOSPHORAMIDITE COMPOUND AND METHOD FOR PRODUCING OLIGO-RNA | Nippon Shinyaku Co., Ltd. (JP) | 2007-06-13 | — | — | EP | claimed |
| US-20060041115-A1 | Methods for preparing oligonucleotides having chiral phosphorothioate linkages | ISIS PHARMACEUTICALS, INC. | 2006-02-23 | — | — | US | claimed |
| US-6002021-A | Process for preparing 6(R)-{2-8'(S)-2\",2\"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1999-12-14 | — | — | US | claimed |
| US-5629134-A | SOLVENT, ALKALI SOLUBLE RESIN, ACID GENERATOR, PYRIDINE SALT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-05-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041115-A1 | Methods for preparing oligonucleotides having chiral phosphorothioate linkages | RNGTT, NUDT1, NSUN2 | NAPRT 560/4885TSHR 2535/4885TDP1 707/4885 |
| US-20250092075-A1 | GLYCOSYLATION METHOD INVOLVING TRIVALENT IODINE REAGENT | UGGT1, GALE, ST6GAL1 | NAPRT 225/4885TSHR 52/4885TDP1 1607/4885 |
| US-20250161506-A1 | Antibody Drug Conjugate Based on Metal N-Heterocyclic Carbene Complex, a Method of Preparing the Same and the Use of the Same in Anticancer Treatment | CTSB, EGFR, GZMB | NAPRT 2670/4885TSHR 616/4885TDP1 4618/4885 |
| US-20250171409-A1 | PROCESS OF PREPARATION OF INDOXACARB AND ITS INTERMEDIATES | DDT, IDO2, INSR | NAPRT 1206/4885TSHR 407/4885TDP1 4151/4885 |
| US-20070282097-A1 | Phosphoramidite Compound And Method For Producing Oligo-Rna | NSUN2, NSUN3, XRN2 | NAPRT 2442/4885TSHR 1960/4885TDP1 986/4885 |
| US-20260121082-A1 | METAL-AIR CELL WITH PERFORMANCE ENHANCING ADDITIVE | SOD1, TMCO1, LETM1 | NAPRT 3633/4885TSHR 2387/4885TDP1 2432/4885 |
| US-12275753-B2 | Glycosylation method involving trivalent iodine reagent | UGGT1, GALE, ST6GAL1 | NAPRT 225/4885TSHR 52/4885TDP1 1607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.